People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amarantus Bioscience Holdings, Inc. | — | Pharmaceuticals | Seed | $6.0M | $11.4M | 2013 |
Mark L Benedyk at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark L Benedyk on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Harris | 1 | 9 |
| David Lowe | 1 | 5 |
| Robert L. Harris | 1 | 4 |
| Robert Farrell | 1 | 4 |
| Mark E Benedyk | 1 | 2 |
| Marc Faerber | 1 | 2 |
| Iain Ross | 1 | 2 |
| Gerald E Commissiong | 1 | 1 |
| John Commissiong | 1 | 1 |
| Dr. John W Commissiong | 1 | 1 |
| Gerald Commissiong | 1 | 1 |
| Donald Huffman | 1 | 1 |
| Steven Spence | 1 | 1 |
| Marc E Faerber | 1 | 1 |
| Robert E Harris | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.